Medicare Enrolled
Dr. Prithipal Sethi, M.D.
Urology Physician · Sacramento, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sethi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sethi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sethi
Dr. Prithipal Sethi is an urology physician in Sacramento, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sethi performed 103,263 Medicare services across 3,338 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sethi received a total of $110,520 from 60 pharmaceutical and/or device companies across 486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sethi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 2% volume in CA
$110,520 industry payments
Medicare Practice Summary
Medicare Utilization ↗103,263
Medicare services
Top 2% in CA for urology physician
3,338
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,737 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
57,202 | $0 | $0 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
21,200 | $5 | $10 |
| Denosumab injection (Prolia/Xgeva) | 16,560 | $18 | $25 |
| Leuprolide injectable, camcevi, 1 mg | 1,933 | $66 | $117 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,391 | $65 | $150 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,104 | $8 | $50 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
477 | $47 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
434 | $97 | $180 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
380 | $30 | $120 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
311 | $11 | $30 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
244 | $191 | $600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
235 | $108 | $250 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
225 | $4 | $20 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
218 | $759 | $1,500 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
151 | $34 | $100 |
| Simple change of bladder tube | 148 | $63 | $125 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
145 | $44 | $125 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
106 | $315 | $600 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
93 | $93 | $200 |
| Complicated change of bladder tube A complex surgical procedure to replace or modify a urinary diversion tube or conduit. This involves intricate manipulation of the urinary tract to ensure proper drainage and function. |
91 | $107 | $300 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $47 | $100 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
73 | $10 | $120 |
| Complicated insertion of bladder tube | 69 | $112 | $300 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
65 | $44 | $200 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
54 | $1,095 | $1,800 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
51 | $27 | $75 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
48 | $19 | $50 |
| Injection, garamycin, gentamicin, up to 80 mg | 42 | $2 | $13 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
39 | $185 | $600 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
34 | $115 | $250 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
27 | $275 | $700 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $77 | $200 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
11 | $49 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
93.5% medium
6.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$110,520
Total received (2018-2024)
Avg $15,789/year across 7 years
Top 4% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
486
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$44,269 (40.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$32,805 (29.7%)
Other
Charitable contributions, space rental, and other categories
$19,346 (17.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,100 (12.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,587
2023
$27,885
2022
$3,911
2021
$8,520
2020
$18,896
2019
$26,594
2018
$4,126
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Olympus America Inc.
$19,346
Dendreon Pharmaceuticals LLC
$202
PFIZER INC.
$160
Ferring Pharmaceuticals Inc.
$124
Boston Scientific Corporation
$120
Bayer Healthcare Pharmaceuticals Inc.
$116
Astellas Pharma US Inc
$90
Clinical Laserthermia Systems Americas Inc.
$88
Myriad Genetic Laboratories, Inc.
$49
Sumitomo Pharma America, Inc.
$41
Telix Pharmaceuticals
$35
Janssen Biotech, Inc.
$34
Laborie Medical Technologies Corp.
$32
SUN PHARMACEUTICAL INDUSTRIES INC.
$31
Novartis Pharmaceuticals Corporation
$28
COLOPLAST CORP
$27
AstraZeneca Pharmaceuticals LP
$26
Endo USA, Inc.
$21
Merck Sharp & Dohme LLC
$19
Top 3 companies account for 95.7% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$45,221
Olympus America Inc.
$19,892
ACCORD HEALTHCARE, INC.
$18,241
Sumitomo Pharma America, Inc.
$8,333
Teleflex LLC
$7,599
Myovant Sciences Inc.
$1,584
HealthTronics Mobile Solutions, LLC
$852
Dendreon Pharmaceuticals LLC
$792
Janssen Biotech, Inc.
$749
Astellas Pharma US Inc
$630
Accord Healthcare, Inc.
$626
Coloplast Corp
$471
TOLMAR Pharmaceuticals, Inc.
$445
Ferring Pharmaceuticals Inc.
$408
Boston Scientific Corporation
$406
Augmenix, Inc.
$332
PFIZER INC.
$265
Clinical Laserthermia Systems Americas Inc.
$240
Palette Life Sciences, Inc.
$237
Amgen Inc.
$236
Allergan Inc.
$197
PROCEPT BioRobotics Corporation
$193
Bayer HealthCare Pharmaceuticals Inc.
$171
Endocare, Inc.
$163
PALETTE LIFE SCIENCES, INC.
$160
Merck Sharp & Dohme LLC
$160
Bayer Healthcare Pharmaceuticals Inc.
$160
AstraZeneca Pharmaceuticals LP
$151
Myriad Genetic Laboratories, Inc.
$144
Endo Pharmaceuticals Inc.
$126
Allergan, Inc.
$117
AbbVie, Inc.
$102
AbbVie Inc.
$100
KOELIS Inc.
$91
Merck Sharp & Dohme Corporation
$85
AngioDynamics, Inc.
$83
Rochester Medical Corporation
$72
Blue Earth Diagnostics Limited
$61
COLOPLAST CORP
$54
180 Medical, Inc.
$54
Avadel Specialty Pharmaceuticals, LLC
$49
Sun Pharmaceutical Industries Inc.
$37
Telix Pharmaceuticals
$35
Retrophin, Inc.
$33
UroGen Pharma, Inc.
$33
Laborie Medical Technologies Corp.
$32
SUN PHARMACEUTICAL INDUSTRIES INC.
$31
Novartis Pharmaceuticals Corporation
$28
Tolmar, Inc.
$26
Smith+Nephew, Inc.
$25
Bard Access Systems, Inc.
$24
BioTissue Holdings, Inc.
$23
Foundation Medicine, Inc.
$21
Endo USA, Inc.
$21
Alnylam Pharmaceuticals Inc.
$21
RGH Enterprises, Inc.
$19
Verity Pharmaceuticals Inc.
$17
AMAG Pharmaceuticals, Inc.
$16
Otsuka America Pharmaceutical, Inc.
$16
Travere Therapeutics, Inc.
$13
Top 3 companies account for 75.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · DALVANCE · EDEX · ELIGARD · ERLEADA · Endocare Cryocare System · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · HD CAMERA HEAD · ILLUCCIX · INTRAROSA · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lofric Origo · Lupron Depot · MAGIC3 · MOBILE LASER UNIT · Mobile Cryoblation Services · Mobile Laser Services · NANOKNIFE · NEOX · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PRECISETUMOR · PROLARIS · PROVENGE · Porges Coloplast · Prolaris · REZUM · SOLESTA · SPEEDICATH · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · Stravix · TITAN · Thiola · Titan · Trelstar · Trinity · UROLIFT · UROLIFT SYSTEM · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZERBAXA · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (40%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for urology physician in CA.
Geographic Context
Urology physicians within 10 mi
73
Per 100K population
4.6
County median income
$88,724
Nearest hospital
METHODIST HOSPITAL OF SACRAMENTO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sethi is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with consulting-driven industry engagement in the top 4% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sethi experienced with testosterone injection?
Based on Medicare claims data, Dr. Sethi performed 57,202 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sethi receive payments from pharmaceutical companies?
Yes. Dr. Sethi received a total of $110,520 from 60 companies across 486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sethi's costs compare to other urology physicians in Sacramento?
Dr. Sethi's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sethi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Sacramento
Browse urology physicians in Sacramento ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Olympus America Inc. Payments to Doctors
See all physicians who received payments from Olympus America Inc.
By company
ACCORD HEALTHCARE, INC. Payments to Doctors
See all physicians who received payments from ACCORD HEALTHCARE, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology